Preoperative Delay & Education Benefits Arthroplasty Patients A randomized study shows having patients waiting for knee arthroplasty undergo a preoperative program of weight loss, exercise, etc gave them modestly improved pain/function/quality of life. https://t.co/RSFwhFKq8U https://t.co/xgyQ65mUAO

Stills Dz Rx w/ IL-1 or IL-6 inhib may mask Dx of MAS! Study of 162 systemic JIA & MAS (62 on biologics). Biologic Rx pts had lower Plt, Ferritin (1107 vs 2863(, CRP (15 vs 90), ESR, fever duration. 27% on IL1/IL6i did not meetMAS classification criteria https://t.co/RmAzxh459R https://t.co/SXroqNBLSZ

Can Mycophenolate be Stopped in Stable SLE? https://t.co/cDmarnHjAN https://t.co/YgG1jbP4Pw

EMR study identified 3.5+ million pts w/ BMI >30 -- 23% had sleep apnea (OSA). OSA had >2 fold risk of gout (7.2% vs 2.8%)vs those without OSA (p<0.0001). The odds of having gout are 2.65 times higher(HR 2.39; (CI) 2.367-2.419, p<0.0001). https://t.co/GgWrAiFPds https://t.co/QuQUk7nwDK

COVIDs Extended Risk for Rheumatic Disease Annals of Internal Medicine reports a large, binational study finding SARS-CoV-2 infection was associated with an increased risk for AIRDs that extends up to 12 months after infection. https://t.co/AIFc3B2YDP https://t.co/TzP49i6br8

85 pts w/ Myositis by MRI. Abnl MRI patterns correlated w/: - Honeycomb & foggy w TIF1γ or Mi2+, MSA-neg DM/PM, SRP+, HMGCR+ - Honeycomb w Cancer (OR 6.8), Gottrons(OR 8) - Foggy w weakness (OR 11.2) - Dense dot w dysphagia (OR 6.3) & CA https://t.co/kZGuNLFglg https://t.co/lK93U5iY7q

Review of autoimmune Dz & adverse preg outcomes: Incr risk of: - Miscarriage w/ Sjögrens (RR 8.85) & SLE (OR 4.9) - Preeclampsia w/ SLE (OR 3.2) - IUGR w/ scleroderma (OR 3.2) & celiac (OR 1.71) - Preterm birth w/ SLE (OR 2.79). https://t.co/PdxJTK6mw3 https://t.co/ToQXgRoEsS

12 Best Hospitals in the USA according to Newsweek 1 Mayo Clinic 2 Cleveland Clinic 3 Johns Hopkins 4 MGH 5 UCLA Med Center 6 Stanford Hospital 7 Brigham & Womens 8 Mount Sinai NYC 9 Northwestern 10 University of Michigan 11 Cedars-Sinai 12 UCSF https://t.co/AJnJsWr4eY https://t.co/M2Abicf4eD

Sandoz has announced FDA approval for their two interchangeable biosimilars of denosumab - Wyost (denosumab-bddz) and Jubbonti (denosumab-bddz) based on reference products Xgeva and Prolia https://t.co/5OmJHDYWmM https://t.co/iHsqlJ9wYl

DESIR study: new onset SpA pts followed w/ Xrays x 10 yrs showed progression from nr-axSpA to r-axSpA was 5.8% (in 294 followed 10 yrs), best predicted by baseline SI bone marrow edema, (OR 6.2), male, Sxs >1.5 yr, ASDAS ≥2.1 & smoking (only in HLA-B27+). https://t.co/A3Qqy8Eeym https://t.co/1I4UFI4h92

Lancet - Full Read Review of the Diagnosis and management of ANCA-associated vasculitis by Stone, et al https://t.co/dtXOU8GT8p https://t.co/OXxdE8REGA

Sniffles & Arthritis (3.1.2024) Dr. Cush reviews the news and journal reports from the past week on RheumNow. Are these associations with infection, biomarkers and weather real or imaginary? Linked or luck? Causal or casual? You decide.... https://t.co/xqoaycXeIm https://t.co/zQdXoj680T